1 min read
Add as a preferred source on GoogleMaxCyte Q3 Revenue Rises 49.3% as EPS Loss Beats Estimates
Revenue reached $10.2 million, including $8.2 million in core revenue and $2 million tied to its SPL program.
MaxCyte, Inc. posted third-quarter 2026 revenue of $10.2 million, up 49.3% year over year, while its GAAP loss per share came in narrower than estimates.
Revenue exceeded estimates by $2.73 million. The company recorded a GAAP loss of 5 cents per share, 3 cents better than estimates.
Core revenue was $8.2 million, and SPL program-related revenue totaled $2 million. An earlier preliminary Q3 core revenue estimate put core revenue at about $8.1 million.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.